Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Work In Process: 2021-2024

Historic Work In Process for Protagonist Therapeutics (PTGX) over the last 4 years, with Dec 2024 value amounting to $165.0 million.

  • Protagonist Therapeutics' Work In Process rose 1550.00% to $165.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $165.0 million, marking a year-over-year increase of 1550.00%. This contributed to the annual value of $165.0 million for FY2024, which is 1550.00% up from last year.
  • As of FY2024, Protagonist Therapeutics' Work In Process stood at $165.0 million, which was up 1,550.00% from $10.0 million recorded in FY2023.
  • In the past 5 years, Protagonist Therapeutics' Work In Process ranged from a high of $165.0 million in FY2024 and a low of $10,000 during FY2022.
  • For the 3-year period, Protagonist Therapeutics' Work In Process averaged around $58.3 million, with its median value being $10.0 million (2023).
  • In the last 5 years, Protagonist Therapeutics' Work In Process tumbled by 99.36% in 2022 and then skyrocketed by 99,900.00% in 2023.
  • Protagonist Therapeutics' Work In Process (Yearly) stood at $1.6 million in 2021, then crashed by 99.36% to $10,000 in 2022, then soared by 99,900.00% to $10.0 million in 2023, then spiked by 1,550.00% to $165.0 million in 2024.